Sachdeva Sakshi, Ramakrishnan Sivasubramanian, Choubey Mrigank, Koneti Nageswara Rao, Mani Kalaivani, Bakhru Shweta, Gupta Saurabh Kumar, Gangopadhyay Debasree, Kasturi Soumya, Mishra Jayashree, Nayak Hemant Kumar, Sivakumar Kothandam, Bobhate Prashant, Awasthy Neeraj, Das Debasis, Chakrabarti Manisha, Muthukumaran Chinnaswamy Sivaprakasam, Saileela Rajan, Dhulipudi Bhargavi, Chaudhary Shiv Kumar, Jayranganath Mahimarangaiah, Saxena Anita, Iyer Krishna Subramony, Kumar Raman Krishna, Kothari Shyam S, Kulkarni Snehal, Rao Suresh G
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Hyderabad, Telangana, India.
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):269-277. doi: 10.4103/apc.apc_134_21. Epub 2021 Aug 26.
Outcome data of children with heart disease who acquired COVID-19 infection are limited.
We sought to analyze outcome data and identify risk factors associated with mortality in children with heart disease and grown-ups with congenital heart disease (GUCH) who had a laboratory-confirmed COVID-19 infection.
This is a retrospective, multicentric, observational study.
The study included children with heart disease and GUCH population, who presented with either symptomatic or asymptomatic COVID-19 infection to any of the participating centers. COVID-19-negative patients admitted to these centers constituted the control group.
From 24 pediatric cardiac centers across India, we included 94 patients with a median age of 12.5 (interquartile range 3-96) months and 49 (52.1%) patients were males. Majority (83 patients, 88.3%) were children. One-third of the patients ( = 31, 33.0%) had acyanotic congenital heart disease, and 41.5% ( = 39) were cyanotic, with > 80% of the patients being unoperated. Only 30 (31.9%) patients were symptomatic for COVID-19 infection, while the rest were incidentally detected positive on screening. A total of 13 patients died (case fatality rate: 13.8%). The in-hospital mortality rate among hospitalized patients was significantly higher among COVID-19-positive cases (13 of 48; 27.1%) as compared to COVID-negative admissions (9.2%) during the study period ( < 0.001). On multivariate analysis, the independent predictors of mortality among COVID-19-positive cases were severity of illness at admission (odds ratio [OR]: 535.7, 95% confidence interval [CI]: 6.9-41,605, = 0.005) and lower socioeconomic class (OR: 29.5, 95% CI: 1.1-814.7, = 0.046).
Children with heart disease are at a higher risk of death when they acquire COVID-19 infection. Systematic preventive measures and management strategies are needed for improving the outcomes.
感染新型冠状病毒肺炎(COVID-19)的心脏病患儿的预后数据有限。
我们试图分析预后数据,并确定实验室确诊感染COVID-19的心脏病患儿和先天性心脏病成人患者(GUCH)的死亡相关危险因素。
这是一项回顾性、多中心观察性研究。
该研究纳入了患有心脏病和GUCH的人群,他们在任何参与中心出现有症状或无症状的COVID-19感染。这些中心收治的COVID-19阴性患者构成对照组。
我们纳入了来自印度24个儿科心脏中心的94例患者,中位年龄为12.5(四分位间距3 - 96)个月,49例(52.1%)为男性。大多数(83例,88.3%)是儿童。三分之一的患者(n = 31,33.0%)患有非青紫型先天性心脏病,41.5%(n = 39)为青紫型,超过80%的患者未接受手术。只有30例(31.9%)患者有COVID-19感染症状,其余患者在筛查时偶然检测为阳性。共有13例患者死亡(病死率:13.8%)。在研究期间,COVID-19阳性病例的住院患者院内死亡率(48例中的13例;27.1%)显著高于COVID阴性入院患者(9.2%)(P < 0.001)。多因素分析显示,COVID-19阳性病例中死亡的独立预测因素是入院时疾病严重程度(比值比[OR]:535.7,95%置信区间[CI]:6.9 - 41,605,P = 0.005)和社会经济阶层较低(OR:29.5,95% CI:1.1 - 814.7,P = 0.046)。
心脏病患儿感染COVID-19时死亡风险更高。需要系统的预防措施和管理策略来改善预后。